Analysis shows intravoxel incoherent motion features predict pathologic complete response to neoadjuvant chemotherapy in breast cancer, highlighting the model's clinical utility.
Motivation: Radiomics research based on whole tumors is limited by the unclear biological significance of radiomics features, which therefore lack clinical interpretability. Goal(s): We aimed to determine whether features extracted from subregions defined by habitat imaging could identify breast cancer patients who will benefit from neoadjuvant chemotherapy (NAC). Approach: We builded models for predicting pCR based on whole-tumor radiomics (ModelWH), intravoxel incoherent motion-based habitat imaging (ModelHabitats), conventional MRI features (ModelCF), and immunohistochemical findings (ModelIHC). Results: In the prediction of pCR, ModelWH, ModelHabitats, ModelCF, ModelIHC, ModelHabitats+CF, and ModelHabitats+CF+IHC achieved AUCs of 0.549, 0.708, 0.700, 0.788, 0.745, and 0.891 respectively, in the test set. Impact: The habitat model combined with conventional MRI features and IHC findings accurately predicted pCR before NAC.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: